A delegation from CNIC Corporation Limited led by its Chairman Yubo Zhou, and CEO Yuxian Zhou, visited Tuspark Cambridge. They were accompanied by Zhigang Ma, Board of Directors of TUS Holdings and Chairman of the TUS Financial Group, and Ming Yang, CEO of the TUS-S&T Service Group.
The delegation was received by Sir Greg Winter, Master of Trinity College, University of Cambridge. Mr Zhou warmly congratulated Sir Greg for his achieving the Nobel Prize in chemistry this year.
Mr Zhou also introduced the investment activity of CNIC and its investment strategy in the UK. He hoped to see an increase in collaborations between the UK and China through TusPark Cambridge as a gateway to TUS Holdings’ innovation ecosystem in China. He saw this as an exchange, facilitating the transfer of Chinese enterprises through TusPark UK.
Sir Greg welcomed CNIC by presenting the history of Trinity College and its famous alumni, such as Isaac Newton. He said Trinity not only produced 33 Nobel winners, but also built the first and most successful science in Europe – the Cambridge Science park.
Sir Greg had developed a drug based on his research around phage display to create adalimumab, a biopharmaceutical product, one of the top selling pharmaceutical products in the world. This experience demonstrated the combination of industry and technology that Cambridge uniquely possesses.
CNIC viewed several projects of Tuspark Cambridge, while Mr Ma spoke about the deep collaboration between TUS Holdings and CNIC, which was a fundamental platform for Tsinghua University.
TUS Holdings is committed to serving society though technology and innovation, building the largest innovation network in the world; and CNIC promotes collaboration between enterprises both in China as well as across the world.
The delegation also visited several more high-tech enterprises in Cambridge Science Park.